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ABSTRACT 1 
Mass spectrometry-based approaches have enabled important breakthroughs in quantitative proteomics in the last 2 
decades. This development is reflected in the better quantitative assessment of protein levels as well as to understand 3 
post-translational modifications and protein complexes and networks. Nowadays, the focus of quantitative proteomics 4 
shifted from the relative determination of proteins (i.e., differential expression between two or more cellular states) to 5 
absolute quantity determination, required for a more-thorough characterization of biological models and comprehension 6 
of the proteome dynamism, as well as for the search and validation of novel protein biomarkers. However, the physico-7 
chemical environment of the analyte species affects strongly the ionization efficiency in most mass spectrometry (MS) 8 
types, which thereby require the use of specially designed standardization approaches to provide absolute quantifications. 9 
Most common of such approaches nowadays include (i) the use of stable isotope-labeled peptide standards, isotopologues 10 
to the target proteotypic peptides expected after tryptic digestion of the target protein; (ii) use of stable isotope-labeled 11 
protein standards to compensate for sample preparation, sample loss, and proteolysis steps; (iii) isobaric reagents, which 12 
after fragmentation in the MS/MS analysis provide a final detectable mass shift, can be used to tag both analyte and 13 
standard samples; (iv) label-free approaches in which the absolute quantitative data are not obtained through the use of 14 
any kind of labeling, but from computational normalization of the raw data and adequate standards; (v) elemental mass 15 
spectrometry-based workflows able to provide directly absolute quantification of peptides/proteins that contain an ICP-16 
detectable element. A critical insight from the Analytical Chemistry perspective of the different standardization 17 
approaches and their combinations used so far for absolute quantitative MS-based (molecular and elemental) proteomics 18 
is provided in this review. 19 
 20 
 21 
 22 
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 25 
Abbreviations: MS: mass spectrometry, HPLC: high-performance liquid chromatography, SRM: selected reaction 26 
monitoring, MRM: multiple reaction monitoring, ESI: electrospray ionization, MALDI: matrix-assisted laser 27 
dissociation/ionization, IDMS: isotope dilution mass spectrometry, SIL: stable-isotope labeled, ICP-MS: inductively 28 
coupled plasma mass spectrometry, PTM: post-translational modification.  29 
2 
I. INTRODUCTION 1 
A main scientific challenge is the understanding of an organism. The sequencing of human genome (Lander et al. 2001, 2 
Venter et al. 2001) implied a huge step towards this goal, as it led to the identification and mapping of human genes that 3 
carry genetic information. Nevertheless, comprehensive study of biological processes cannot be achieved just from the 4 
genomics perspective. Different biomolecules play important roles in such processes, among which proteins stand out 5 
clearly (Liebler and Yates 2012). Understanding the proteome is therefore sine qua non for a full comprehension and 6 
clear view of the processes that occur in an organism. 7 
The proteome is, however, much more complex than the genome due to the so-called dynamism of the proteome. 8 
Although proteins are gene-translation products, there is no 1-to-1 correspondence because, whereas there are around 9 
20,000 genes in the human genome, the number of proteoforms might amount up to 1,000,000 (Muñoz and Heck 2014). 10 
Once proteins are translated in the ribosomes from mRNA, they can undergo modifications, named post-translational 11 
modifications (PTMs), whose extent varies with individual proteins, regulatory mechanisms within the cell, and 12 
environmental factors. On the other hand, proteins functions are not based solely on their individual roles or actions, but 13 
also from protein-protein interaction networks, which regulate the function and eventual biological activity of the protein 14 
components of the network (Jeong et al. 2001). In addition, the diversity in the abundance range of proteins is another 15 
with proteomic studies. As an example, human protein levels can vary more than 10 orders of magnitude in serum, from 16 
the tens of mg·mL
-1
 of albumins to the low pg·mL
-1 
interleukins (Anderson and Anderson 2002). 17 
This complexity of the proteome implies that it cannot be understood just from known genomic information. Protein 18 
locations or modifications (which are directly responsible for the particular regulation and activity of a given protein), are 19 
not visible and barely predictable at the DNA/RNA level. That is, proteomics studies are indispensable to identify the 20 
different proteins, to study their regulation mechanisms and possible PTMs, to understand protein-protein interactions 21 
and, last but not least, to quantitatively determine protein abundances and protein levels variations in healthy and disease 22 
status. In this regard, the eventual construction and elucidation of the human proteome map (Kim et al. 2014, Wilhelm et 23 
al. 2014) resulted in a remarkable breakthrough towards functional proteomics understanding. 24 
Protein identification and subsequent generation of protein catalogs have significantly aided one to understand protein 25 
biological activity. Nevertheless, this sort of information is not sufficient, and the capability assess not only protein-level 26 
variations between two states, but protein absolute quantities is necessary in order to properly address a comprehensive 27 
characterization of proteome dynamism (Hoofnagle et al. 2011). The capability to determine protein and PTM quantities 28 
might help to assess concentration changes of relevant proteins during biogenesis, in the modifications of cellular states, 29 
as well as to reveal biomarker proteins responsible for the appearance of several diseases or even potential targets for 30 
drug development to cure such diseases. Moreover, such quantitative information is required for research of biological 31 
systems as a whole (systems biology), hence head towards development of mathematical models and algorithms to 32 
describe and simulate complex biological processes carried out through proteins (e.g., signaling networks within the 33 
cell). 34 
3 
A. The role of mass spectrometry in quantitative proteomics 1 
Traditionally, quantitative proteomics approaches included electrophoresis separations with UV detection (O’Farrell 2 
1975, Von Eggeling et al. 2001), immunochemistry techniques with radioactive, luminescence or fluorescence detection 3 
(Yalow and Berson 1960, MacBeath 2002), and immunoblotting techniques. Immunoassays-based techniques have been 4 
at the lead in proteomics studies in the last decades, especially since the development of the major immunoassay-based 5 
methods used for targeted quantitative proteomics, the enzyme-linked immunosorbent assay (ELISA) (Engvall and 6 
Perlmann 1971), and the development of the Western Blotting (Towbin et al. 1979). ELISA’s excellent sensitivity and 7 
throughput to quantify proteins even at low pg·mL
-1
 levels allows for a rather straightforward validation of biomarker 8 
candidates if high quality antibodies are available. Moreover, the possibility to study PTMs, protein weight, or location 9 
of antibody epitopes provided by Western Blotting have made them both “gold standards” in targeted protein 10 
quantification. 11 
Advances in mass spectrometry (MS), genomic sequencing, and bioinformatics have revolutionized proteomics studies in 12 
molecular and cell biology research in the last decades. MS-based proteomic approaches can routinely identify thousands 13 
of known and novel proteins and/or protein PTMs events contained in biological samples (Aebersold and Mann 2003, 14 
Domon and Aebersold 2006). Additionally, MS might provide higher-quality quantitative data because typically, MS 15 
experiments can use several peptides of the protein as standards, and the robustness of such peptide assays can be 16 
independently verified in each laboratory, study, and sample type. In contrast, the analytical performance of 17 
immunoassays-based approaches cannot be properly tested because the antibodies might not be sufficiently 18 
characterized, and the specificity and absence of cross-reactivity in the response signal cannot be always assured. 19 
Moreover, the observed lack of reproducibility in measurements with different sets of reagents and the unavailability of 20 
reference samples have been also highlighted (Hoofnagle and Wener 2009, Aebersold et al. 2013). Still, MS has not 21 
completely replaced immunoassays in quantitative proteomics, most notably in clinical analysis and validation, and 22 
therefore immunoassay-based techniques remain an important tool in this framework. This situation is the result of 23 
insufficient quality assurance of MS-based approaches, which lack controls and calibrators for quantitative results 24 
validation (Regnier et al. 2010, Boja et al. 2014). 25 
Even so, MS is the leading trend in proteomics studies and is called to lead in the near future studies of the proteome and 26 
functional characterization of biologically important genes. In this sense, molecular-based methods with soft-ionization 27 
sources, such as ESI (electrospray ionization) and MALDI (matrix-assisted laser desorption/ionization) are the reference 28 
approaches today. The attainable high sensitivity, resolution, and acquisition rates make ESI-MS an exceptionally useful 29 
tool to analyze complex proteomic samples, particularly with high-performance liquid chromatography (HPLC) 30 
separation, to enable simultaneous and multiplex quantitative detection in a single measurement of target peptides (Pan et 31 
al. 2009, Hawkridge 2014). In contrast, MALDI-based MS offers some unique features in proteomics studies, 32 
particularly the dissociation of LC separation from sample introduction before MS analysis, to allow separate sample 33 
preparation and mass spectrometric analysis. Moreover, MALDI enables a non-destructive sample analysis, the 34 
predominant generation of single-charge ions and, very importantly today, the ability to perform targeted protein imaging 35 
analysis (Hortin 2006, Gessel et al. 2014). The high sensitivity of the technique, combined with the possibility of direct 36 
solid analysis on tissue samples, makes MALDI-MS a powerful technique for protein distribution profiling and 37 
biomarkers discovery with differential imaging approaches (Cornett et al. 2007, Franck et al. 2009, Hajduk et al. 2016). 38 
4 
In parallel with the more-common molecular MS approaches, elemental mass spectrometry with inductively coupled 1 
plasma (ICP) ionization is also important for quantitative proteomic analysis, due to its capacity to determine 2 
“heteroatoms” (any element in biologicals except C, H, N, and O) and isotopes present or artificially included (labels) in 3 
a given biomolecule. ICP-MS robustness for ionization, which can be translated into quantification without the need for 4 
specific standards, is at the basis to explain why ICP-MS is a rising complementary approach to the more widely 5 
established molecular-based approaches (Łobiński et al. 2006, Sanz-Medel et al. 2008). 6 
B. The challenge of absolute quantification 7 
Most quantitative proteomics approaches, especially in large-scale analysis, compare a proteome in a sample under study 8 
related to a reference state (Ong and Mann 2005). That is, they are relative quantifications that provide fold changes 9 
between target samples (e.g., abundance ratios of the sought protein in both samples), or relative differential expression 10 
or regulation of such proteins in at least two compared biological states. Of course, the information provided by such 11 
inter-study sample comparisons in the determination of protein contents is only relative unless a standardized reference 12 
sample is used. In contrast, an “absolute” quantification to provide actual determination of the total amount or 13 
concentration of the individual protein(s) of interest in a single proteome is the focus of present proteomic analysis. 14 
Absolute quantification turns up as a more-accurate and -reproducible tool for systems biology applications (Box 1), 15 
especially to establish predictive interaction models for such biological systems. In order to build up these models, 16 
experimental data and absolute quantitative information on a set of protein concentrations, their changes, their 17 
degradation rates, or PTM levels might be of utmost importance (Brönstrup 2004). 18 
In this vein, some approaches adopted for relative quantifications might also be used for absolute quantification 19 
(Bantscheff et al. 2012), provided that there are reference standards available for all analytes or their amount added to the 20 
samples for the quantitative analysis is known. Such general analytical approaches exploit the well-established concept in 21 
analytical chemistry of “internal standardization”, in which a known amount of a differentiated, but as similar as possible 22 
to the analyte (usually isotope-labeled), well-characterized standard is added to the sample in such a way that the 23 
measured response ratio between the target analyte and the standard is used to quantify it in absolute terms. Figure 1 24 
schemes the timeline of such internal standardization in most common molecular MS-based absolute quantitative 25 
proteomics approaches. 26 
Most current absolute quantitative proteomics approaches suffer from the hindrance that the analyte is a different 27 
chemical species than the standard at the beginning of the experiment. The soundness to translate quantities 28 
experimentally obtained (especially after time-consuming sample preparation procedures) into actual quantity of the 29 
peptide/protein in the sample is questionable (Zhang et al. 2013). The reliability of the eventual quantification can be 30 
greatly affected by protein losses or degradation during sample preparation and/or the completeness of protein digestion 31 
if a bottom-up approach is used. In other words, it is still possible that the absolute protein concentration derived from 32 
those standard-base MS strategies does not accurately reflect the actual protein level originally present in the biological 33 
sample. Therefore, absolute protein quantification is not yet a universal quantification method. As a matter of fact, a large 34 
and certified absolute quantification peptide/protein set of standards does not exist yet. Their availability would be the 35 
first requisite to apply quality-assurance protocols in quantitative proteomics. In fact, absolute quantifications can only be 36 
carried out on a limited number of known target proteins and peptides, and are mainly limited by the need for synthetic 37 
and appropriately characterized peptide/protein standard in each case. 38 
5 
II. NON-ISOTOPE LABELED STANDARDIZATION APPROACHES 1 
MS-based quantitative proteomics today comprises “bottom-up” workflows, in which proteins are enzymatically digested 2 
into peptides prior to their MS study, and “top-down” workflows, in which intact proteins are directly analyzed with MS.  3 
In targeted “bottom-up” approaches, proteins are mostly identified from a match of masses of observed hydrolyzed 4 
peptides and the corresponding MS/MS fragments with theoretical values in a database. Peptide quantification is 5 
performed by comparison of the MS peak intensities of the different isotope-labeled (e.g., heavy versus light) peptides. In 6 
the specific case of targeted absolute proteomics workflows, previously obtained information on the analyte is used to 7 
generate MS-based assays to detect and quantify corresponding predetermined target peptides. Quantification of the 8 
target peptides is usually performed through the spike of samples with adequate peptide standards (as “signature” or 9 
“proteotypic” peptides) that are chemically synthesized incorporating enriched stable isotopes, and comparing the 10 
measured intensities of the light (endogenous) and the heavy (standard) peptides (Schmidt and Urlaub 2012). One of the 11 
major downsides of such methods, nonetheless, is that the primary stable isotope-labeled reagents needed for the 12 
synthesis are not easy to obtain and are usually expensive. Besides, the cost and time to synthesize, purify, and certify the 13 
stable isotope standard peptides for the desired absolute quantitation, as well as setting up spike-in experiments and 14 
standard curves, can be substantial. The high cost of the synthesized isotope labeled standards continues to make such 15 
determinations of clinically relevant proteins comparatively expensive for routine analysis (Kirkpatrick et al. 2005, Brun 16 
et al. 2007). 17 
In this context, the use of the so-called “label-free” approaches is today a clear trend in proteomics, and have the 18 
potential to be at the lead of the new developments in quantitative proteomics in the recent future (Cox et al. 2014). 19 
These approaches mostly employ computational resources for the quantification by a comparison of the intensity signals 20 
or the average spectra matched to a peptide or protein obtained from MS analysis (Bantscheff et al. 2012). However, they 21 
might require internal standards for MS signal normalization, because at their current state they still lack the robustness 22 
and reproducibility required, and for the production of absolute quantitative data. 23 
Another alternative to the use of SIL standards is to tag directly the tryptic peptides present in different samples with 24 
isobaric tags. These tags have a constant overall mass, so that the final mass of the same tryptic peptides present in 25 
different samples is still identical and will elute together in the LC-MS analysis after sample mixing (Ong and Mann 26 
2005, Maes et al. 2016a). The different isotopic composition of the component parts of such tags are different, so 27 
different MS/MS fragments are observed for each chromatographic peak, which correspond to the different samples 28 
analyzed. Hence, multiplex quantification can be carried out. Of course, absolute quantification is affordable if one of the 29 
samples analyzed correspond to a standard with known protein concentrations. 30 
Furthermore, ICP-MS-based approaches are currently gaining momentum as they can provide absolute protein 31 
quantification without the need for specific standards (stable-isotope labeled or not) and any type of tagging. 32 
MS-based quantitative methods that do not make use of stable-isotope labeling are reviewed in the following sections. 33 
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A. Non-isotope labeled standardization approaches with molecular mass spectrometry 1 
1. Standardization in quantitative label-free MS 2 
Labeling methodologies require complex, time-consuming sample preparation and reactions and can be relatively 3 
expensive. In contrast, label-free quantification is by nature the simplest and more-economical approach. It is, in 4 
principle, applicable to any kind of sample, including materials that cannot be labeled, and there is no virtual limit on the 5 
number of samples that can be compared/quantified. However, despite the long-standing interest of protein quantification 6 
without (isotopic) labels in the proteomics field, the accurate and robust proteome-wide quantification via label-free 7 
approaches remains a challenge. 8 
Label-free quantification is generally based on the comparison either of the mass signal intensities (spectrometric spectral 9 
counts) for selected proteolytic peptides or the number of peptide-sequencing events observed for the samples/analytes to 10 
be analyzed (Chelius and Bondarenko 2002, Aebersold and Mann 2003, Liu et al. 2004). The intensity values of each 11 
peptide in one controlled (reference) experiment can be compared with their respective intensities in one or more other 12 
experiments to yield relative quantitative information (Neilson et al. 2011, Schilling et al. 2012). With appropriate 13 
computational tools, it is possible to infer the difference in protein abundance between two different biological states. 14 
The interest in label-free quantification is growing lately because, even though label-free methods suffer from 15 
compromised quantification accuracy (because there is less quantitative control in the analytical procedure steps), the 16 
label-free algorithms can approximate the protein ratios between samples. Therefore, these methods can be appropriate 17 
when large-fold changes are expected and approximate comparisons are enough (Staunton et al. 2014). 18 
Even though these label-free strategies are mostly limited to relative quantification, absolute quantitative approaches 19 
have been also reported, such as emPAI (exponentially modified protein abundance index), APEX (absolute protein 20 
expression), and iBAQ (intensity-based absolute quantification). emPAI uses an exponential expression that considers 21 
the number of observed and observable peptides per protein, which is proportional to the absolute protein abundance and 22 
might be converted into absolute concentrations after measuring total protein amounts by BCA assay (Ishihama et al. 23 
2005). APEX is an spectral count method combined with computational normalization, in which absolute protein 24 
abundance is obtained from relating the protein abundance in the sample and the number of experimentally obtained and 25 
predicted peptide observations per protein (Lu et al. 2007). These label-free strategies hold great potential for quantitative 26 
proteomics, being able to estimate protein abundance levels with acceptable levels of accuracy (Arike et al. 2012, Fabre 27 
et al. 2014), though they still present several practical limitations. High precise, reproducible, and accurate raw data are 28 
vital, as well as an exhaustive control and minimization of variations in the sample preparation, chromatographic, and 29 
MS performances. These experimental variations, regardless of their source, can be accounted for, provided that 30 
appropriate internal standards are used (Ong and Mann 2005, Holman et al. 2016). Table 1 summarized the use of such 31 
internal standards in label-free approaches. 32 
On the other hand, iBAQ transforms normalized protein intensities into estimated protein copy numbers, by means of 33 
relating the sum of the MS intensities of all peptides matching to a certain protein, and the number of theoretically 34 
observable tryptic peptides of the protein (iBAQ intensity) (Schwanhäusser et al. 2011). In this work, iBAQ intensity was 35 
correlated to protein quantities by means of using a spike-in commercial protein set standard, hence protein standards 36 
concentration was accurately known. These protein standards were used to build a calibration curve (log-iBAQ intensity 37 
7 
vs log-protein molar amount), so that the linear regression could then be used to transform iBAQ intensities into actual 1 
absolute quantities for all proteins identified in the sample. 2 
Alternatively, Winter and coworkers introduced a “label-free” quantitative approach, which is based on the use of 3 
minimally permuted peptide analogues (MIPA) (Winter et al. 2010). MIPA introduces a positional permutation of two 4 
related amino acids on a synthetic standard peptide. Because the amino acid composition of the MIPA and the master 5 
peptide is the same, MS ionization efficiency will be very similar. Nevertheless, the fragments produced in the MS/MS 6 
analysis will differ due to the differentiation in the peptides sequences produced by the permutation. MIPA-based 7 
absolute quantification can be carried out from comparison of peak areas from MS or MS/MS spectra, depending on 8 
whether the targeted and MIPA-peptides elute at different retention times or co-elute, respectively. 9 
2. Isobaric tagging in molecular MS 10 
During the past few years, several isobaric tagging strategies have been developed and play important roles to compare 11 
different biological samples (differential proteomics) that generally resort to shotgun proteomics methods. The mass-12 
labeling basis in these procedures is directed by the reactive group of certain amino acids of the protein with the tag. 13 
Consequently, such approaches are limited to proteins or peptides that contain those certain amino acid residues. The 14 
reporter section of the tagging reagents is different for each sample/protein and provides different fragments in the 15 
MS/MS analysis, whereas the “balance” section equilibrates any mass difference, so that every tag (reporter and balance 16 
section) has the same final mass. 17 
More than a decade ago, Ross and coworkers (Ross et al. 2004) developed a methodology based on this alternative mode 18 
of labeling named iTRAQ (isobaric tag for relative and absolute quantitation). The iTRAQ reagent is tagged to proteins 19 
or tryptic peptide sides at the N-terminus amino group and the side chain of Lys (Figure 2.A). The resulting isobaric-20 
tagged protein/peptides are mixed, and subjected to fractionations and to LC-MS/MS analysis for quantification. Due to 21 
the isobaric nature of the labeling reagents, the same peptide from each sample appears as a single peak in the MS 22 
spectra. However, after the MS/MS fragmentation, the tags will produce diagnostic, low-mass MS/MS signature ions in 23 
such a way that the signal intensity ratios of these signature ions indicate relative proportions (ratios of downregulation or 24 
overexpression) of the corresponding peptides/proteins/samples (Wiese et al. 2007). iTRAQ technology enables relative 25 
comparison of differential expression levels using different iTRAQ reagents (4- and 8-plex). This approach, however, 26 
requires from high accuracy and reproducibility of the LC-MS/MS performance, and the use of an internal standard can 27 
be addressed in order to correct for instrumental variations (Fuller and Morris 2012).  28 
Moreover, absolute protein quantification can also be obtained using the iTRAQ workflow (Ross et al. 2004). In this 29 
regard, Quaglia and coworkers evaluated the applicability of iTRAQ for absolute protein quantification. They combined 30 
the spiking of SIL peptides in a somatropin sample, with iTRAQ derivatization (after tryptic digestion), in order to 31 
determine peptide and hence protein concentration from the area ratio of the iTRAQ reagent reporter ion in both, tryptic 32 
and SIL peptides. To do so, they used a calibration mixture of two synthetic SIL and non-labeled somatropin peptides, 33 
which were treated likewise to the sample, so that quantification could be addressed with both IDMS and iTRAQ 34 
approaches. This strategy enabled the validation with IDMS of the iTRAQ-based quantification of somatropin protein. 35 
Quantitative results with both approaches were equivalent, though iTRAQ offered lower precision than IDMS (Quaglia 36 
et al. 2008). Still, these strategies offer higher accuracy than label-free approaches, which in contrast can provide higher 37 
8 
proteome coverage and increased dynamic range. However, iTRAQ is limited by inherent problems such as fold-change 1 
underestimation or isotopic impurities of the iTRAQ label (Evans et al. 2012), and by the need of efficient protein 2 
digestion, and reproducible and complete protein/peptide derivatizacion (Quaglia et al. 2008).  3 
Together with iTRAQ, isobaric labeling with “tandem mass spectrometry tags” (TMTs) holds great popularity. These 4 
tags, similarly to iTRAQ reagents, consist on a peptide-reactive group (NHS ester) and the isobaric tag, which comprises 5 
a reporter group (based on N-methylpiperazine) and mass-balance group (Thompson et al. 2003). The reporter and mass-6 
balance group masses are different through the use of different isotopes, but in such a way that the mass of the isobaric 7 
tag is the same in all the TMT reagents (Figure 2.B). Dayon and coworkers have exploited the quantitative multiplexing 8 
capabilities of TMTs -with the use of six-plex isobaric tandem mass tagging (Dayon et al. 2008). Later on, McAllister 9 
and coworkers increased the multiplexing capability of the method with ion isotopologues with isobaric masses, in which 10 
a 
15
N was replaced by a 
13
C, which therefore requires high-accuracy mass spectrometers to resolve the induced mass shift 11 
(McAlister et al. 2012); two years later, the use of 10-plex TMT tags was reported (Werner et al. 2014). As was the case 12 
with iTRAQ, proof-of-concept of the use of TMTs for absolute quantification was also developed in parallel. In the work 13 
by Dayon and coworkers, potential protein biomarkers of brain-damage disorders from cerebrospinal fluid were 14 
quantified in absolute terms by means of a calibration curve. To build up this curve, 4 identical mixtures at different 15 
concentrations of TMT-labeled synthetic proteotypic peptide standards of such proteins were measured by MS/MS, and 16 
therefore relate the reporter ion intensity and the known peptide concentration (Dayon et al. 2010). Despite applicability 17 
and linearity of the approach was further validated with standard addition method using synthetic standard peptides, 18 
results showed variability among peptides from the same protein, which the authors attributed to different factors, such as 19 
the existence of PTMs, the tryptic digestion performance, or the different stability and recovery among peptides. 20 
In the use of isobaric tags, one of the main issues to take care of is the potential errors or effects that might happen during 21 
sample preparation, and separations that can affect the quality and validity of the MS/MS quantitative results. These 22 
effects can be corrected via statistical approaches or normalization methods of the measured experimental peptides 23 
intensities by resorting to constrained optimizations and taking into account information about the labeling strategy 24 
(Maes et al. 2016a). 25 
B. Non-isotope labeled standardization approaches with elemental mass spectrometry 26 
ICP-MS analytical features for elemental trace analysis include potential species-independent signal response of any 27 
element-containing species, excellent limits of detection (down to ng·L
-1
), as well as linear dynamic range of up to 10 28 
orders of magnitude.  As a consequence, it is important as a complementary alternative to better-established molecular 29 
MS-based  quantitative approaches, particularly for absolute quantitative proteomics (Wang et al. 2010). In this regard, 30 
ICP-MS can be applied to quantify virtually all proteins by means of the direct determination of naturally present ICP-31 
MS-detectable heteroatoms (e.g. metals, S, P, or Se) or after appropriate element tagging  to the target species (Sanz-32 
Medel et al. 2012), as schemes Figure 3. 33 
1. Direct quantification of peptide/proteins using elemental MS 34 
Even though the four major elements present in proteins (C, H, O, N) cannot be directly measured with ICP-MS, there 35 
are elements (including metals, semimetals such as Se, or non-metals such as S or P) naturally present in proteins whose 36 
9 
quantitative measurement can be used for the absolute direct quantification of proteins and peptides. Of course, complete 1 
species isolation is required because ICP-MS does not distinguish between the elemental signals coming from different 2 
co-eluting species. To achieve such protein determination, the corresponding stoichiometry element:protein is required as 3 
well. Due to the virtual species-independent nature of the ICP-MS ionization (Sanz-Medel et al. 2012), absolute 4 
quantifications can be approached with even inorganic compounds that contain the measured heteroatom as calibration 5 
standards (Svantesson et al. 2002). 6 
ICP-MS detection of the non-metallic elements typically present in proteins (i.e., S, P, Se) has been traditionally 7 
hampered and only very recent instrumental advances, mostly based on a triple quadrupole configuration for more 8 
efficient interference removal  (Diez Fernández et al. 2012), enabled their highly sensitive detection. ICP-MS-based 9 
studies in quantitative proteomics had been specifically focused on analysis of the metallic and semi-metallic 10 
heteroatoms present in (metallo)proteins. Metalloproteins contain coordinated metals (e.g., Zn, Fe, Cu, etc.) within the 11 
protein structure to provide them with important biological activities (e.g., enzymatic, storage or transport). 12 
Consequently, ICP-MS-based quantification of the metallic heteroatom can produce relevant information about its effect 13 
in the biological activities and functions of the proteins (Sanz-Medel et al. 2012). Furthermore, the knowledge of the 14 
fixed metal:protein stoichiometry enables one to obtain information of protein quantities from the quantitative detection 15 
of the metallic heteroatom. Even though ICP-MS-based quantification of metalloproteins is more based on the use of 16 
isotope dilution (see III.B section), it is possible to determine the quantity of the metallic heteroatom bound to the protein 17 
by means of external calibrations of known concentrations of metalloproteins (Hare et al. 2013, 2016). These studies are 18 
limited, nonetheless, by the stability and strength of the protein-heteroatom union through the analytical procedure and 19 
measurement, because metal-protein complex instability (especially during the LC separation step) can ruin the 20 
quantitative results (Sarmiento-González et al. 2008). Consequently, the possibility to precisely detect heteroatoms 21 
covalently joined to the protein structure is of high interest. 22 
In this sense, one of the most-promising direct targets for such heteroatom-based quantitative studies is sulfur. Because it 23 
is present in cysteine and methionine residues, sulfur is statistically present in almost all proteins. In fact, sulfur is not 24 
only a potential candidate for absolute quantification of proteins via ICP-MS, but for special studies of phosphorylation 25 
degrees and metalloproteins stoichiometries (Wind et al. 2003, Szpunar 2005). In any case, application of direct sulfur 26 
measurement to eventual species quantification is limited by the need to separate with LC the typically very abundant 27 
sulfur-containing analytes with quantitative recoveries from the column. This is especially critical in the case of intact 28 
protein analysis. Even so, the continuous advances in HPLC together with triple quadrupole ICP-MS technology head 29 
towards the possibility of absolute quantification of both peptides (Diez Fernández et al. 2012) and intact proteins 30 
(Calderón-Celis et al. 2016). In fact, if correction of the ICP-MS sensitivity along the LC gradient is achieved, absolute 31 
quantification of several intact proteins in relatively simple mixtures using a single S-containing generic standard, spiked 32 
to the sample prior to the LC-ICP-MS analysis, becomes possible. In this line, hybrid LC-MS configuration with both 33 
elemental and molecular MS detection has the potential to in parallel identify and quantify intact proteins directly (Figure 34 
4) (Calderón-Celis et al. 2017). The potential applicability of such approach depends on the availability of robust 35 
platforms to achieve pre-MS separation of each and every protein species.  36 
Another important elemental target in quantitative proteomics studies is phosphorous. Unlike sulfur, phosphorous is 37 
monoisotopic, i.e., only a single stable isotopic form, 
31
P. The direct measurement of phosphorous in proteins is most 38 
relevant today to investigate one of the most important PTM, phosphorylation. Of course, as with sulfur, phosphorylation 39 
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quantification requires the knowledge of stoichiometry phosphorous:protein. Nonetheless, phosphorous is not as common 1 
as sulfur in protein structures. This fact is important because it enables one to use phosphorous elemental determination 2 
for direct detection (screening) of phosphorylated of proteins in complex biological systems (Maes et al. 2016b). 3 
Notably, such approaches also show great potential to assess quantitatively the many procedures commonly used for 4 
purification, preconcentration, and/or isolation of peptides in proteomics studies, as already demonstrated specifically for 5 
phosphopeptides enrichment strategies (Pereira Navaza et al. 2008). 6 
After prior developments in the ICP-MS analysis of phosphorous for the determination of the phosphorylation degree in 7 
proteins (Wind et al. 2001), and the absolute and site-specific quantification of protein phosphorylation (Pereira Navaza 8 
et al. 2007, 2008), in 2009 Zinn and coworkers proposed a method based on the use of phosphorous-based absolutely 9 
quantified standards peptides (PASTA) for the absolute quantification of phosphorous-containing peptides 10 
(phosphorylated peptides) (Zinn et al. 2009). Such synthetic peptides, which were also stable-isotope labeled, could be 11 
quantified in absolute terms by calibration with a P-containing generic standard. Once their concentration is certified, 12 
these PASTA peptides can be used for quantitative purposes in LC-ESI-MS analyses, after their dephosphorylation with 13 
protein phosphatase. 14 
In this line, the recombination of proteins expressed in a selenomethionine-containing media led to exchange of 15 
methionine amino acids by selenomethionines to generate standards named RSIQ (recombinant isotope-labeled and 16 
selenium-quantified). These standards can also carry an isotopically labeled amino acid (i.e., 
13
C) for subsequent use in 17 
quantitative proteomics with molecular MS approaches. From the fact that such RSIQ protein standards carry selenium-18 
containing amino acids, quantification with ICP-MS measurement of the selenium enables absolute determinations of the 19 
selenoprotein as well (Zinn et al. 2010). 20 
2. Direct protein tagging for ICP-MS based quantification 21 
Whereas the measurement of naturally present heteroatoms enables direct quantification of proteins, phospho- and 22 
selenoproteins and almost any metalloprotein with ICP-MS (Sanz-Medel et al. 2012), the use of non-present heteroatoms 23 
as labels offers also some unique features. Artificial elemental labeling enables the quantification of proteins or peptides 24 
that otherwise could not be quantified with ICP-MS when the peptide or protein does not contain ICP-detectable 25 
heteroatoms, or the required sensitivity cannot be achieved by the direct measurement of naturally present heteroatoms. 26 
In this sense, the chemical labeling of the sought peptide/protein molecule with bifunctional reagents that contain the 27 
heteroatom (Figure 5.A), mostly rare-earth elements, can enhance the ICP-MS sensitivity due to low ionization potential 28 
and lack of interferences. Great multiplexing capabilities due to the number of potential heteroatoms (and isotopes) are 29 
also available (Tholey and Schaumlöffel 2010, Sanz-Medel 2016). The potential of this type of labeling and its 30 
multiplexing capabilities with ICP-MS detection is clearly shown by the development of a novel “mass cytometry” 31 
technique, as an alternative to conventional flow cytometry. This technique consists of the labeling of cell components 32 
with recognition molecules (mostly antibodies) that carry rare earth elements (and isotopes) that enable quantitative 33 
analysis with ICP and a ToF-MS analyzer (CyTOF). Thereupon, further understanding of multiple features of cellular 34 
systems and multi-parametric biological functions is possible by broadening the experimental toolbox for systems 35 
biology investigations (Bendall et al. 2011).  36 
11 
In this line, “metal-coded affinity tags” (MeCAT) use a chelate complex that contains rare-earth elements as metal tags 1 
(Ahrends et al. 2007). This complex also contains a reactive group for covalent labeling to the amino acids (Figure 5.B). 2 
The protein or peptide quantity is determined directly by the assessment of the metal element signal with ICP-MS. 3 
Further, Bergmann and coworkers carried out “top-down” and “bottom-up” MeCAT quantifications (Bergmann et al. 4 
2012) applying MeCAT labeling to peptides and intact proteins. Metal quantification with FIA-ICP-MS of the lanthanide 5 
label amount enabled final absolute protein concentration evaluation. 6 
Depending on the nature of the quantitative study, a more-specific tag could be required, as is the case of mercury tags 7 
after their bonding to thiol groups of the sought amino acid residues (cysteine). There are some examples of this 8 
particular approach that use tags such as small mercury compounds (Guo et al. 2008) or p-hydroxymethilbenzoate 9 
(Kutscher and Bettmer 2009) (Figure 5.C). Concerns about toxicity, together with the limited applicability of the 10 
approach (selective reactivity to just cysteine), make this tagging a rather academic solution. 11 
Moreover, many peptides might not have a S-reactive group prone to react with a more standard chelating complex (e.g., 12 
MeCAT and mercury labeling). Therefore, a wide range of target sites for elemental labeling is desirable. This is the 13 
particular case with tyrosine (Tyr)-containing peptides that can selectively react with bis(pyridine)iodonium 14 
tetrafluoroborate (IPy2BF4), leading to the bioconjugation of two iodine atoms to the metapositions of the activated 15 
aromatic ring. Therefore, iodine labeling can be used to quantify peptides/proteins that contain Tyr amino acids with the 16 
ICP-MS measurement of iodine (Figure 5.D). Again, a simple iodine-containing standard, such as iodobenzoic acid, can 17 
be used as a generic standard for the Tyr-containing peptides/proteins previously labeled (Pereira Navaza et al. 2009). 18 
Interestingly, iodine ICP-MS detection is much more sensitive than phosphorous or sulfur although, in turn, it is less 19 
sensitive than lanthanides. 20 
3. Antibody tagging in immunoassay approaches with ICP-MS detection 21 
An alternative to heteroatom bioconjugation with the peptide/protein of interest is the use of bifunctional reagents, which 22 
contain the heteroatom bound to an adequate protein-recognition moiety, such as a specific antibody (see Figure 3). 23 
We have already commented that quantification of proteins based on immunoassays have been a major method due to 24 
their good sensitivity, selectivity, and throughput, especially the ELISA method. Immunoassays are usually combined 25 
with luminescence techniques to provide fast and simple detection. However, it has been demonstrated that ICP-MS 26 
detection in immunoassays can overcome some limitations of luminescence detection, such as matrix effects; and 27 
therefore they do not require extra sample-preparation steps. Enhanced sensitivity is provided as well (Montoro Bustos et 28 
al. 2012). Still, immunoassay-based approaches entail negative issues, inherent to the use of antibodies, that concern 29 
cross-reactivity, reagent antibodies saturation, or lack of repeatability among measurements and sensitivity (Hoofnagle 30 
and Wener 2009). 31 
Combination of immunoassays with ICP-MS detection was first introduced as an excellent and sensitive alternative for 32 
quantitative proteomics (Zhang et al. 2001a). In brief, an antibody that reacts specifically to the target protein is used. 33 
This antibody is tagged with an elemental label, which can be measured with ICP-MS. This label can be a metal ion, such 34 
as europium
 
(Zhang et al. 2001a), a polymer chain ligand that contains lanthanides (Lou et al. 2007, Majonis et al. 2010) 35 
or magnetic nanoparticles that contain the detected heteroatom (Peng et al. 2011), among others. These approaches 36 
combine the high-selectivity characteristics of recognition reactions of immunoassays with the highly sensitive detection 37 
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of metal elements in ICP-MS, besides the capability to detect different elemental isotopes to provide multiplexing 1 
capabilities (Sanz-Medel 2016). In this vein, Bendall and coworkers have reported the labeling of around 30 (epitope-2 
specific) antibodies with different elements and isotopes for multiplexed cell analysis by ICP-MS-based mass cytometry 3 
analysis (Bendall et al. 2011). 4 
In addition, the possibility to use metallic nanoparticles (NPs) as antibody labels instead of single elements allows 5 
enhanced sensitivity for protein quantification because they might be formed by thousands of atoms (Sanz-Medel et al. 6 
2008, Liu et al. 2014). Numerous types of NPs with very different and unique physicochemical properties have been 7 
used, including gold nanoparticles (AuNPs), silver nanoparticles (AgNPs), silver deposited upon AuNPs, lead 8 
nanoparticles (PbNPs), nanoclusters (NCs), and quantum dots (QDs) (López-Serrano et al. 2014). Interestingly, many of 9 
those NPs exhibit photoluminescence properties as well. The use of these kind of labels for quantification requires the 10 
corresponding bioconjugation reaction between NP and antibody to be well-characterized and under control. Regarding 11 
quantification, typical immunoassay calibration curves are typically carried out. However, if the elemental composition 12 
of the nanoparticle and the stoichiometry nanoparticle:antibody are known, then the approach has the potential to provide 13 
quantification without the need for specific standards because the elemental determination could be directly translated 14 
into protein amounts. Still, as in many cases for immunoassays, the selectivity remains an important issue and cross-15 
reactivity as well as unspecific interactions are important concerns to take care of. 16 
In addition, if the elemental sensitivity achieved with nanoparticles is not enough, this kind of label enables one to resort 17 
to the so-called “amplification” procedures. After the immunoassay has been successfully carried out, the nanoparticle 18 
can act as seed, and an elemental layer can be deposited upon it, so that at the end a much bigger nanoparticle is 19 
measured. It is worth stressing that the direct use of such bigger nanoparticles is not as effective because the recognition 20 
capabilities of the antibody could be compromised. In this manner, the measured analyte contains a much higher number 21 
of elemental atoms to amplify enormously the ICP-MS signal and so enhance significantly the detection limits beyond 22 
the fg ml
-1
 level (Garcia-Cortes et al. 2016).  23 
III. STABLE-ISOTOPE LABELED STANDARDIZATION APPROACHES  24 
Ever since the introduction of the concept of stable-isotope labeling for the quantification of peptides (Desiderio and Kai 25 
1983), it has become a roaring trend in targeted quantitative proteomics. Typically, the synthetic standard peptides are 26 
synthesized with an incorporated stable heavy isotope label (mostly 
2
H, 
13
C, 
15
N, 
18
O) on one or more selected amino 27 
acids in their sequences. These synthetic reference standard peptides, or proteins, mimic their endogenous natural 28 
counterparts (the analyte), in such a way that they share the same physicochemical properties, including chromatographic 29 
co-elution, ionization efficiency, and fragmentation pattern. However, whereas identical chromatographic retention time 30 
can be guaranteed with 
13
C, 
15
N or 
18
O labeling (Zhang and Regnier 2002), for 
2
H labeling the actual retention time might 31 
be notoriously changed to likely affect quality of the quantitative results, because conditions at the ESI source will not be 32 
identical for both isotopologues (Zhang et al. 2001b). 33 
Such stable-isotope labeled (SIL) standards only differ from the analyte in their isotopic compositions. Therefore, there is 34 
a well-known defined mass difference so that they can be unambiguously distinguished and easily detected with MS. 35 
Because the isotope label is perceived by the mass spectrometer as a shift in the m/z ratio, and they are introduced into 36 
13 
the sample at a known concentration, the relative ratios of the resulting peptide pairs are a direct measure of the absolute 1 
concentration of the target peptides/proteins in such sample. Of course, accuracy of the measurement depends also on the 2 
ability to discriminate from possible interfering signals (Mallick and Kuster 2010) in the MS and MSMS spectra. One 3 
way to achieve this discrimination is to resort to high mass resolution analyzers or, alternatively, to reduce the sample 4 
complexity through sample fractionation or via computational means (Zhang et al. 2010). 5 
A. Stable-isotope labeled standardization approaches with molecular mass spectrometry 6 
Targeted absolute quantitative proteomics with HPLC-MS make use of such specific isotope-labeled peptides or proteins 7 
standards, which are spiked into the sample at known concentration for each targeted peptide or protein to be determined. 8 
1. Peptide-based approaches 9 
The vast majority of these strategies resort to synthetic isotope-labeled standards, analogous to proteotypic peptides of 10 
the species of interest. The main approaches are AQUA (Absolute Quantification), in which quantification is 11 
accomplished by means of spiking the sample with the adequate heavy synthetic peptide (Gerber et al. 2003), and 12 
QconCAT (Quantification Concatemer), which makes use of a synthetized isotopically labeled protein built by 13 
concatemerization of several proteolytic peptides of the target protein(s) under study (Beynon et al. 2005). 14 
Typically, AQUA methodology consists of addition of the proper synthetic SIL peptide, physically and chemically 15 
identical to the endogenous part, and of known concentration, into the experimental sample to obtain absolute 16 
quantitative data (Desiderio and Kai 1983, Gerber et al. 2003, Kirkpatrick et al. 2005). Quantification is carried out with 17 
MS detection and “selected” (SRM) or “multiple” (MRM) reaction monitoring on the basis of the measured intensity 18 
ratio of both peptides, natural and labeled (easily detected as pairs of signals separated by a known and constant Δm). 19 
Because the concentration of the labeled peptide added to the sample is known, the amount of the natural peptide can be 20 
determined from the signal ratio. However, one important issue is the initial estimation of the concentration of the labeled 21 
standard to be used, because the protein(s) of interest might be present in a broad range of concentration levels in the 22 
sample. This limitation can be overcome with a preliminary MRM measurement (Kirkpatrick et al. 2005). Moreover, SIL 23 
peptides cannot be used in the initial isolation step of the protein from the sample, and thereby the reproducibility 24 
assurance of this sample preparation step is a must. 25 
Typical requisites for such internal standard SIL peptides are: (i) they should be proteotypic in order to avoid peptides 26 
with the same sequence from different proteins, (ii) efficiently ionizable in order to provide a good detection by MS, and 27 
(iii) peptides with PTMs or that might be subjected to polymorphism should be avoided. The election of the proteotypic 28 
peptides to be used as standards in quantitative proteomics is usually approached in an empirical mode, and makes use of 29 
those peptides that have been previously sequenced in a shotgun experiment, because chromatographic and ionization 30 
properties can be controlled. Nevertheless, if such information is not available, then bioinformatics prediction programs 31 
can be used as well to choose potential tryptic peptides (Mallick et al. 2007).   32 
Of course, proteotypic peptides should be previously synthesized and certified. Generation of peptide standards is 33 
commonly addressed by stepwise chemical synthesis; solid-phase peptide synthesis (SPPS) is the method of reference 34 
(Figure 6.A)  (Merrifield 1963). This approach produces peptides through the assembly of the amino acids onto a solid 35 
14 
polymer support [e.g., cross-linked poly(dimethyl acrylamide] or polystyrene resins). In the case of stable-isotope 1 
enriched peptide standards, they can be generated by using the corresponding isotope labeled amino acids, usually 2 
enriched in the C-terminal in Lys or Arg, with 
15
N and 
13
C (Gerber et al. 2003). However, in the course of the chemical 3 
synthesis, some peptides can suffer from artificial modifications over time, and several residue- or sequence-dependent 4 
side reactions can also occur during the SPPS process, such as the formation of diketopiperazine or aspartimide (Amblard 5 
et al. 2006), which results in potential errors in the final absolute measurements. For these reasons, synthesis strategies 6 
based on biological, rather than chemical, approaches are popular. These strategies are based on the in vitro expression of 7 
an amino acid sequence from a specific gene in a biological media. In the case of isotopically enriched standards, the 8 
growing cell culture media is enriched in the desired isotopically enriched amino acids, usually arginine and lysine 9 
(metabolic labeling) (Bantscheff et al. 2012). Even though peptides can be directly synthesized with metabolic 10 
approaches, the synthesis of proteins (as will be seen later) using their specific encoding gene is more common, as they 11 
can be digested after the synthesis in order to produce the target proteotypic peptides.  12 
Once generated the stable isotope-labeled synthetic peptide standards, the concentration of such standard has to be 13 
correctly certified in terms of purity in order to obtained accurate quantitative results. The most-common and -extended 14 
approach for peptide/protein certification is amino acid analysis (AAA), which provides quantitative information on the 15 
amino acid content of peptides or proteins as well as their amino acid composition after a hydrolysis step (mostly acid) to 16 
break the peptide bonds of the peptides or proteins. AAA presents a series of issues to take into account, such as (i) the 17 
acid hydrolysis, which can produce chemical modifications or degradations in the amino acids when too rough conditions 18 
are employed, obligating to the control and optimization of this procedure (Rutherfurd and Gilani 2009); (ii) the low 19 
efficiency of the acid hydrolysis for long amino acid sequences, which hampers the applicability of AAA to intact 20 
proteins quantification; (iii) the high amount of starting materials; (iv) its lack of specificity, because AAA detects 21 
aminoacids independently of the original peptide; and (v) the requirement for highly purified peptides, which usually 22 
implies purity assessment (Fountoulakis and Lahm 1998, Mirzaei et al. 2008). An alternative approach to amino acid 23 
analysis is chemiluminescent nitrogen detection (CLN). CLN enables the direct determination of the peptide content even 24 
in crude mixtures in contrast to AAA. The CLN approach consists of the burning of the compounds to achieve 25 
combustion of the nitrogen. Nitric oxide species formed react with ozone in a specific chemiluminescent reaction and 26 
emit light in the red and infrared region of spectrum. The intensity measured with a photomultiplier tube is directly 27 
proportional to the amount of nitrogen in the sample (Fujinari et al. 1996). Nevertheless, the methodology lacks 28 
robustness and selectivity, because any compound in the sample that contains nitrogen would contribute to the signal 29 
emitted, including those containing ammonia, hydrazine, or nitrogen oxides.  30 
On the other hand, the proven advantageous features of elemental MS (ICP-MS) for quantitative element detection of 31 
heteroatoms point to ICP-MS as an increasingly attractive alternative for protein and peptide standard certification. In 32 
this case, given that the signal of the detected element is directly proportional to its absolute amount and independent of 33 
the chemical species where it is present, the certification of the concentration of the peptide standards can be directly 34 
assessed with calibrations via a single generic standard as simple as an inorganic or organic pure compound (Sanz-Medel 35 
et al. 2012). Certification of the peptide concentration through its direct measurement cannot be done unless it contains a 36 
heteroatom (any element different from C, O, H, N and F), such as P, Se, or S. Because most peptides do not contain 37 
heteroatoms, their certification is usually carried out via detection of a heteroatom present in a tag chemically joined to 38 
the protein with strategies commented on Section II.B. 39 
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An important strength of AQUA is its selectivity and rapid development, even though it is not as sensitive as antibody-1 
based immunoassays (ELISA) when is used directly without any enrichment step. Yet, AQUA can be applied to a wide 2 
range of samples, from tissue culture cells to human plasma and tissue; it is limited by instrumentation capabilities; i.e., 3 
the number of proteins that can be measured in a single LC-MS analysis, the duty cycle of the mass spectrometer, and the 4 
actual distribution of AQUA peptides across the LC elution profile. In 2004, a method named SISCAPA (Stable Isotope 5 
Standards and Capture by Anti-Peptide Antibodies), which combined MRM detection with antibody-based selective 6 
enrichment and purification of peptides, was described (Anderson et al. 2004). Briefly, the SIL peptides are spiked to the 7 
sample, which is subjected to enzymatic digestion. The proteolyzed sample is incubated in a medium that contains 8 
antibodies (affinity columns or conjugated to agarose or magnetic beads) that react specifically to the sought peptides to 9 
enable their enrichment.  Finally, the enriched peptide is released and analyzed with LC-MS/MS (Whiteaker et al. 2010). 10 
The advantage of SISCAPA over common approaches is the possibility to combine the sensitivity and specificity of 11 
MRM analysis with the highly selective enrichment capacity of antibodies to produce improved detection limits (Xu et 12 
al. 2015). 13 
In contrast to the AQUA approach, QconCAT technique, first described by Beynon  and coworkers, is based on the use 14 
of artificial proteins, which are concatemers of selected SIL proteotypic peptides characteristic of the target proteins 15 
(Beynon et al. 2005). This SIL standard protein is usually synthesized through concatemerization, expressed from a 16 
plasmid synthetically prepared that contains the designed artificial genes encoding the different target peptides, that are 17 
finally present in the product protein (formed as concatemer of peptides) (Pratt et al. 2006) (Figure 6.B). Nevertheless, 18 
there is an alternative approach named PolySIS (polyprotein stable-isotope labeled internal standard), which uses in vitro 19 
expression (Anderson and Hunter 2006). After addition to the sample and tryptic digestion, the synthetic protein might 20 
provide a SIL standard peptide for each natural proteotypic target peptide/protein, because they carry the isotope label 21 
(usually [
13
C6] arginine and [
13
C6] lysine) from the moment they were expressed. 22 
One of the main concerns in QconCAT is to assure an identical digestion between the SIL designed QconCAT protein 23 
and the target proteins (Mirzaei et al. 2008). In those cases in which the protein sequence is not fully preserved, and 24 
therefore the natural and the labeled proteins both have different amino acid sequences (Scott et al. 2015), the tryptic 25 
digestion efficiency might be affected, especially if the differences in the sequence surround the cleavage sites (Keil 26 
1992) of the target peptides. The importance to assure identical digestion conditions in order to obtain equimolarity of 27 
QconCAT peptides, has led to the inclusion of natural flanking sequences around the cleavage sites of the QconCAT 28 
protein to better mimic  the target protein (Achour et al. 2015). In 2007, the peptide-concatemer standards (PCS) (Kito et 29 
al. 2007) strategy was developed for the accurate quantification of the stoichiometry of the components of the QconCAT 30 
protein with MS. In this strategy, these PCS standards do not only include the SIL tryptic peptides as potential internal 31 
standards for quantification of the target proteins as happens with QconCAT, but also their natural flanking sequences. 32 
Therefore, the cleavage efficiency of the PCS and the target protein is in principle matched to improve quantification 33 
accuracy. Consequently, errors in the digestion efficiency and existence of miscleavages can be better corrected, because 34 
the adjacent aminoacids (which will be cut by the enzyme) are included in both the natural and the standard peptide. 35 
With the use of the PCS strategy, quantitative information regarding the stoichiometry of the components of a multi-36 
protein system can be obtained and what is more important, eventual absolute analytes quantification might be also 37 
provided. In any case, purification and gene-construction processes are limited by larger PCS. For instance, in the study 38 
16 
of multi-protein complexes several PCS need to be used, and the knowledge of the exact amount of each PCS added to 1 
the sample is required.  2 
An important issue that affects not only AQUA and QconCAT, but also any targeted quantitative proteomics approach, is 3 
the selection of the peptide standard for quantification. Computational approaches to predict peptides likely to be 4 
observed using MS are clearly desirable. In this regard, a series of repositories that contain a compendium of MS/MS 5 
proteomics data are available, such as PeptideAtlas (Desiere et al. 2004, 2006), SRMAtlas (Picotti et al. 2008), or PRIDE 6 
(Protein Identifications Database) (Martens et al. 2005). PeptideAtlas is a database framework that contains peptides 7 
sequences and MS/MS data from proteomic experiments. This resource is of public access, so that raw data from 8 
different scientists can be accepted into the repository. Such data are processed and reanalyzed, and finally gathered in a 9 
compendium library (Deutsch et al. 2008). In relation to PeptideAtlas, SRMAtlas is a database that contains specific 10 
information of proteomics assays based on the analysis of proteomes digests with tandem (SRM/MRM) MS, whereas 11 
PRIDE is a database that contains proteomics data on protein/peptide identification as well as localization of PTMs. 12 
These public resources can facilitate the production of predictive algorithms for proteomic analysis, as well as the 13 
estimation of the optimal proteotypic peptides when designing targeted proteomics experiments. To address these points 14 
in QconCAT, Eyers and coworkers have generated two complementary data sets of proteotypic peptides and developed 15 
CONSeQuence, a consensus prediction system built around four independent machine-learning algorithms to better 16 
understand peptide “detectability” (Eyers et al. 2011). 17 
Because absolute quantification of proteins using labeled peptides is carried out through the measured intensity ratio 18 
between the natural and labeled peptides, and this ratio is related to the label peptide concentration in order to determine 19 
the target protein concentration in the sample, spectral overlapping of both peptides must be avoided. For that purpose, 20 
the isotopically labeled analog usually carries multiple tags. Nonetheless, this multi-isotopic labeling can lead to isotopic 21 
effects and hence errors in the measurement of the intensity ratio; thereby methodological calibrations are needed to 22 
correlate the intensity and molar ratios of both peptides (Kuhn et al. 2004). In this sense, González-Antuña and 23 
coworkers developed a strategy based on spectral overlapping between the natural and isotopically labeled peptides, 24 
which are minimally labeled in 
13
C and named MOPs (mapped overlapping peptides) to avoid isotopic effects. This 25 
strategy allowed determination of the molar fractions of both peptide abundances directly from the experimental mass 26 
spectra without need for instrumental calibration (González-Antuña et al. 2015). 27 
2. Intact protein-based approaches 28 
Whereas the use of SIL peptides as quantification standards in approaches such as AQUA and QconCAT is the main 29 
strategy today in absolute quantitative shotgun proteomics, it has some limitations: incomplete coverage of the protein 30 
sequence, the need to characterize and control the proteolysis step efficiency, and the lack of control over sample-31 
preparation steps previous to digestion. Thereby, the natural alternative to overcome such drawbacks is the use of intact 32 
(full-length) SIL protein standards.  33 
The common workflow consists of the addition in known concentrations of the synthetic SIL protein standard to the 34 
sample, at the earliest steps of the analytical process (e.g., to the lysate, tissue, or biological fluid, that contain the sample 35 
proteins). After sample treatment (extraction, fractionation, etc.), the protein extract is digested into peptides, followed by 36 
the LC-MS-MS/MS analysis. Then, absolute quantities of the protein can be determined from the MS ratio of the light 37 
17 
and heavy versions of the tryptic peptides. The main strategies that make use of SIL full-length proteins in absolute 1 
quantitative proteomics are PSAQ (Protein Standard Absolute Quantification) (Brun et al. 2007) and “Absolute SILAC” 2 
(Hanke et al. 2008). Additionally, Wang and coworkers recently develop an strategy for absolute protein quantification 3 
based on the use of SILAC synthesized SIL proteins and non-labeled protein calibrators, named TAQSI (Targeted 4 
absolute quantitative proteomics with SILAC internal standards) (Wang et al. 2016). In this approach, absolute protein 5 
quantification is accomplished using the MS ratio of heavy vs light proteolytic peptides of the proteins, and a calibration 6 
curve built with the non-labeled protein calibrator set. 7 
As it is the case with peptide-based approaches, availability of the specific SIL protein standards is a limitation in 8 
protein-based approaches for absolute proteomics. Full-length protein standard cannot be synthesized with the SPPS 9 
stepwise procedure, because it is limited to small peptides (no more than 50-70 residues) as it is impeded by the 10 
accumulation of side-products from incomplete acylation and cleavage-related side reactions, as well as the time-11 
consuming assembling of the amino acid chain. Thus, the synthesis of longer peptides and proteins via chemical 12 
procedures has to be addressed by coupling protected segments or, even more efficiently, by chemoselective ligation of 13 
non-protected purified sequences to enable a faster assemblage of the peptide chain (Miranda and Alewood 1999). This 14 
approach makes use of reactive functionalities in unprotected ~50-residue peptide segments that form the target protein 15 
(Figure 6.C). The chemical ligation used to bind them can consist, among others, on the formation of a thioester, an 16 
oxime, a directed disulfide, a thioether, a thiazolidine, or a peptide bond in aqueous solution (Dawson and Kent 2000).  17 
Production of SIL proteins to be used as standards is more feasible through biological synthesis, and just requires the 18 
specific gene encoding the protein to be available (Miranda and Alewood 1999, Pratt et al. 2006, Lebert et al. 2011). The 19 
main approach to biologically synthesized isotopically enriched proteins (peptides) for quantification is SILAC (stable 20 
isotope-labeled amino acids for quantification). In this approach, both forms of the proteins (light and heavy) are 21 
synthesized in two culture media, one of which contains a heavy form of a specific amino acid, usually [
13
C] Lys and 22 
[
13
C] Arg. Such SIL amino acid is incorporated into the proteins, which are likely synthesized under same chemical 23 
conditions than those unlabeled proteins in the “light” media with [12C] Lys or [12C] Arg. For further quantitative 24 
purposes, SILAC synthetic proteins need the heavy form of the amino acid to be completely incorporated into its 25 
sequence (Ong and Mann 2007). There are also other biological synthesis approaches described besides SILAC, such as 26 
the PURE (protein synthesis using recombinant elements) approach, which employs commercial kits for the cell-free in 27 
vitro protein expression (Figure 6.D) (Tuckey et al. 2014, Xian et al. 2016); or the FLEXIQuant (Full-Length Expressed 28 
Stable-Isotope-labeled Proteins for Quantification) approach, in which the full-length labeled protein standards are 29 
expressed in vitro, after the gene of interest is cloned into a wheat germ expression vector, and transcribed and translated 30 
in a wheat germ extract (WGE) (Figure 6.E) (Singh et al. 2009). 31 
Likewise to the case of peptides, these synthesized SIL protein standards need to be characterized and certified in order 32 
to be used as quantification standards and ensure quality results. Unsuitability of AAA and limitations of CNL to intact 33 
protein quantification demand for new strategies for full-length protein standards characterization and certification. In 34 
this vein, proven capabilities of ICP-MS for the quantitative analysis of intact proteins (Calderón-Celis et al. 2016) place 35 
this methodology as a feasible alternative, because lack of standards for protein certification result in the need for 36 
compound-independent approaches. In contrast to peptides, large number of amino acids in the protein sequence entails 37 
the presence of at least one cysteine or methionine residue. Consequently, certification of the SIL protein standard 38 
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concentration can be directly addressed through the ICP-MS detection of naturally present elements (principally S) and 1 
use of non-specific standards. 2 
3. Critical comparison of protein- vs peptide-based approaches 3 
As commented in the previous sections, both SIL peptide and protein standards allow absolute quantitative proteomics. 4 
However, there are sources of error that affect final absolute protein quantitative results depending on the type of SIL 5 
standard used. Table 2 summarizes a comparison of the main benefits and limitations of peptides or proteins as standards 6 
for absolute quantification. 7 
Quantitative approaches that measure directly intact proteins are still limited today by the necessity of high mass-8 
accuracy instruments (such as Fourier transform mass spectrometers, FTMS, or linear ion trap (LTQ-Orbitrap), by the 9 
present lack of methods to efficiently fragment large proteins and, above all, by the difficulty to obtain appropriate intact 10 
protein standards. Consequently, most quantitative proteomics approaches finally measure tryptic peptides, and make use 11 
of tandem-MS instruments (Eng et al. 1994, Perkins et al. 1999). The corresponding SIL peptide standards used for 12 
quantification, as shown in Figure 1, can be directly added to the sample (SIL peptides), or can be generated from a 13 
protein standard that undergoes tryptic digestion together with the protein samples (SIL proteins). 14 
Due to their higher flexibility and accessibility to chemical modifications, peptides are most efficiently labeled than 15 
proteins. Of course, standard peptides are much easier to obtain from chemical synthesis as well. Additionally, the use of 16 
peptides instead of proteins provides a better front-end separation and higher sensitivity (Yates et al. 2009). However, 17 
there are several key aspects to take into account when peptides are used as standards for absolute-quantitative 18 
proteomics: mainly the election of the standard, the enzymatic digestion process, and the analytical recovery of the target 19 
proteotypic peptide.  20 
The election of a representative peptide of the protein under study, which normally has to be unique to such protein (the 21 
so-called proteotypic peptide), is critical because some amino acid sequences are common to multiple proteins or protein 22 
isoforms. Therefore, they cannot be used either as conclusive evidence for the presence of the sought protein or for its 23 
specific absolute quantification. Possible PTMs present in the sequence should also be known in order to be used as 24 
signature to probe the quantitative state of a PTM associated with a particular biological state or disease setting. In 25 
addition, peptides with reactive or labile amino acid residues should be avoided such as those that can suffer oxidation 26 
(Met, Cys, and Trp), peptide bond instability (Asp-Pro and Asp-Gly), deamidation (Asp, Glu) or cyclization (N-terminal 27 
Glu) (Pan et al. 2009).  28 
Another critical consideration in SIL peptide-based approaches is the needed proteolytic/enzymatic digestion of the target 29 
protein. This digestion step involves decomposition of intact proteins into a collection of peptides of suitable size for MS 30 
analysis. A 1:1 ratio of the peptide to precursor protein is typically assumed. Therefore, if the digestion is not efficient, 31 
and thus the proteotypic peptide is not quantitatively released, it might affect profoundly the precision and accuracy of 32 
the final quantification. Consequently, control of denaturing conditions during in-solution hydrolysis is crucial for 33 
reliable absolute quantification (Schmidt et al. 2010). In addition, inherent problems associated with protein digestion 34 
such as miscleavages at the sites related to the target peptide must be always considered. Another problem associated 35 
with protein digestion is the chemical modification of the amino acid side chains during the proteolysis. This 36 
modification might compromise the results by changing the molecular mass of the fragments and consequently the 37 
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amount of them eventually detected with MS. Moreover, experimental protocols must be optimized towards high 1 
proteolysis kinetic rates in order to avoid bias resulting from, for instance, peptide modification proceeding faster in the 2 
SIL internal standard added than in the same stretch of sequence within the intact protein, released as a fragment (Arsene 3 
et al. 2008). 4 
Although there are strategies that can simulate the digestion procedure in the peptide standard, by means of incorporating 5 
the peptide flanking amino acid sequence (PCS strategy), they cannot simulate the entire molecular environment of the 6 
protein. The use of intact proteins as (labeled) internal standards offer here some relevant advantages in comparison to 7 
the use of peptides (Table 2) to evaluate and normalize digestion efficiency. Addition of a isotopically labeled version of 8 
the sought protein can correct most of the sources of error during digestion procedures, besides from its usefulness as 9 
potential standard for quantification (Hoofnagle 2010). Nevertheless, intact protein as standards require the labeled 10 
protein must be identical to the endogenous protein and properly and correctly folded. Otherwise, inconsistent tryptic 11 
digestion and cleavage efficiency can be produced (Arsene et al. 2008, Yates et al. 2009). 12 
Moreover, it is commonly accepted in quantitative Analytical Chemistry that the sooner the internal standard is added to 13 
the sample the better, because more inevitable errors during sample preparation steps would be corrected for. Therefore, 14 
a labeled standard should ideally represent the full-length protein, because its use would permit a complete survey and 15 
unbiased quantitative analysis (Zhou et al. 2012, Gregorich and Ge 2014). This strategy enables a much better control of 16 
the analytical process because the standard is added at the beginning of the process, and shares almost identical 17 
biochemical and physicochemical properties with the target protein (Figure 1). Thereby, even prefractionation and 18 
digestion steps errors, losses, or procedure inefficiencies before analysis can be corrected. Moreover, direct analysis of 19 
intact proteins could lead to a more-reliable quantification of the proteins isoforms and PTMs, because traditional 20 
limitations due to the use of peptides for the proteome characterization, including incomplete or ambiguous 21 
characterization of alternative splice forms, PTMs and protein cleavages, can be overcome (Tran et al. 2011). 22 
4. The potential to combine label-free strategies and isotope labelling 23 
Ideally, peptide’s MS signal intensity should be proportional to the absolute abundance of the peptide -and of the 24 
corresponding protein- in the sample. However, such an assumption is, in fact, erroneous because of effects such as 25 
variable sequence-dependent peptide ionization efficiencies, suppression by co-elution with dominant species, missing 26 
observations derived from peak selection in MS/MS analyses, etc. These limitations explain why stable isotope labelling 27 
is the most-extensive approach for absolute proteomics. However, although modern MS/MS measurements are sensitive 28 
and highly reproducible across laboratories and platforms and they could theoretically be extended to a full proteome, 29 
preparation of thousands of isotopically labeled peptides of known concentration is both a formidable and expensive task. 30 
In this way, new methodologies based on the use of MS/MS and isotope labeling strategies in combination with 31 
computational label-free strategies are popular in order to accomplish a more complete absolute quantification coverage 32 
of proteomes (Wepf et al. 2009, Malmström et al. 2009). 33 
In this regard, the average-intensity method estimates a protein abundance from the average mass spectrum peak 34 
intensity of its three best-detected peptides (Silva et al. 2005). The spectral-counting approach takes into account the 35 
observed counts on a number of MS/MS spectra copies attributable to each protein (Liu et al. 2004) and was improved 36 
latter by incorporating differential peptide ionization into the computation (Lu et al. 2007). Malmström and coworkers 37 
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(Malmström et al. 2009) have combined these three concepts in a new approach that considers: (i) SRM measurements of 1 
a limited set of SIL internal reference standards, (ii) the average mass spectrum signal intensities of the top three peptides 2 
selected per protein, and (iii) weighed MS/MS spectral counts. Thereby, the authors combined the absolute quantification 3 
provided by the use of SIL reference peptides with SRM, label-free quantification, and high-throughput proteome 4 
sequencing with LC-MS/MS. Such a combination minimizes the costs of isotopic labeling while maximizing coverage 5 
and accuracy. 6 
On the other hand, another approach based on the combination of isotope labels and label-free quantification was 7 
developed by Wepf and coworkers (Wepf et al. 2009). They quantified bait proteins via isotope-labeled reference 8 
peptides corresponded to an affinity tag sequence and prey proteins with label-free correlational quantification with the 9 
precursor ion signal intensities of proteotypic peptides generated in reciprocal purifications. Of course, proteotypic 10 
peptides must be firstly identified to apply this method. Even though such proteotypic peptides can be computationally 11 
predicted or extracted from proteomic databases, they must be experimentally validated. Furthermore, the applicability of 12 
SIL reference peptides in the affinity purification coupled to tandem MS (AP-MS/MS) workflow is again limited because 13 
their synthesis for a large number of network components is challenging, time-consuming, and expensive (Wepf et al. 14 
2009). 15 
B. Stable-isotope labeled standardization approaches with elemental mass spectrometry 16 
The ICP-MS capacity to simultaneously measure different isotopes of an element enables absolute quantification of 17 
peptide/protein species by the direct measurement of the isotope ratios of the target element in the compound of interest 18 
after appropriate addition of an enriched isotope solution, whose concentration and isotopic abundances are accurately 19 
known. This quantification is based on the concept of elemental isotope dilution analysis (IDA), which consists of the 20 
alteration of the isotope composition of the sample by addition of a known quantity of an isotopically-enriched form of 21 
the same element (Figure 7) (García Alonso and Rodríguez-González 2013). From the measurement of the altered 22 
isotope ratios of the target element, quantification can be accomplished. Requirements for eventual accurate 23 
quantification include the ICP-MS capacity to measure accurately and precisely small variations in that elemental isotope 24 
composition. Of course, the isotopes involved in the ratio must be measured free of spectral interferences. In addition, 25 
isotope-dilution methods require for equilibration of the natural and isotopically enriched elements, which is easily 26 
achieved in the ICP plasma. 27 
There is a wide range of applications in quantitative proteomics based on the elemental IDA concept, mostly classified 28 
into two principal workflows (see Figure 3). The first one makes use of an isotopically enriched standard in the same 29 
chemical form of the analyte (species-specific IDA). On the contrary, the standard containing the sought element 30 
enriched in a heavy isotope is generic without being necessary to be in the same chemical form than the analyte in the 31 
second workflow (species-unspecific or online IDA). 32 
1. Species-specific isotope dilution approaches 33 
In the first case, as in targeted SIL quantitative proteomics with molecular MS approaches, the labeled or synthetic 34 
isotopically enriched form of the target species is spiked into the sample. If this step is done at the beginning of the 35 
process, then errors, losses, or matrix effects that occur along all the analytical processes, including sample preparation, 36 
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digestion, degradation, chromatographic separation, and ICP-MS measurement can be corrected for. In fact, the target 1 
species and its corresponding isotopically labeled standard will arrive to the ICP source simultaneously to allow for the 2 
required elemental isotopic equilibration. In brief, the elemental detection of the different isotopes of the sought element 3 
gives an isotopic ratio. Taking into account that the elemental concentration of the added species-specific spike is known 4 
as well as the isotope abundances of natural and isotope-labeled versions of the compound (or measured previously), 5 
determination of the elemental concentration can be accomplished with this simple elemental isotope ratio measurement 6 
with the so-called “isotope dilution equation” (Wang et al. 2010, García Alonso and Rodríguez-González 2013). Such 7 
elemental concentrations accurately computed can be translated into biomolecule concentration given the known 8 
stoichiometry heteroatom:biomolecule. This approach can be used in quantitative proteomics measuring isotope ratios in 9 
elements either naturally present in the peptides/proteins, or tagged to them, usually with reagent molecules. Hence, 10 
absolute quantification has been reported for either amino acids (Ruiz Encinar et al. 2004, Hermann et al. 2016), peptides 11 
(Deitrich et al. 2016) and even full-length proteins (Harrington et al. 2005, Brauckmann et al. 2016). 12 
2. Species-unspecific isotope dilution approaches 13 
On the other hand, quantitative proteomics with species-unspecific isotope dilution using ICP-MS detection is based on 14 
use of an online continuous addition, commonly after the on-column separation, of a generic species isotopically 15 
enriched in the detected heteroelement, in a known concentration and isotopic composition. Isotopic equilibration 16 
required for the IDA computation between the element-containing target species separated during chromatography and 17 
the generic isotopically enriched element-containing species added and mixed on-line with the chromatographic eluent is 18 
achieved again in the ICP plasma. Thereupon, peptide/protein absolute quantification can be carried out with on-line 19 
continuous monitoring (element mass/time) of the isotope ratio, which can be transformed in a mass-flow chromatogram 20 
with the mass flow equation, derived from the isotope-dilution equation. Integration of the chromatographic peaks of the 21 
different (previously separated) species allows one to calculate directly the mass of the element (Rodríguez-González et 22 
al. 2005). This common application of the concept of on-line IDA (Lásztity et al. 1989, Rottmann and Heumann 1994) 23 
can be used for absolute quantification of peptides/proteins. Again, it can be applied to elements naturally present, such 24 
as iron (Grebe et al. 2012) or sulfur (Giner Martínez-Sierra et al. 2010, Feng et al. 2014), or intentionally added after 25 
labeling with usually lanthanide-containing species such as europium (Patel et al. 2008) or lutetium (Rappel and 26 
Schaumlöffel 2009). This controlled labeling enables quantification of any peptide species, unlike direct quantification 27 
with naturally present elements, in which only peptides or proteins that contain that target element can be quantified. 28 
Given the virtually species-independent nature of ICP ionization, and that the spike is normally added after the 29 
chromatographic separation, this spike does not require the same chemical form than that of the studied species. 30 
Consequently, several different peptide/protein species can be quantified in one analysis and without the need for specific 31 
(labelled or not) standards. Nevertheless, the identity of the species is finally necessary in order to translate the quantified 32 
amount of element in each chromatographic peak into compound quantity, usually accomplished with parallel molecular 33 
mass spectrometry approaches. In that sense, Figure 4 shows a model workflow that described the synergic combination 34 
of elemental MS, which provides quantitative information, and molecular MS, enabling identity and sequence 35 
characterization of the species, as has already been tested for the absolute quantitative profiling of an assayed proteome 36 
(Calderón-Celis et al. 2016).  37 
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In brief, these species-unspecific IDA-based ICP-MS approaches hold great potential for the determination of 1 
biomolecules for which no specific standards are available or when the synthesis of such standards is too complex or 2 
expensive. In fact, ICP-MS capabilities can be of high relevance in quality control and proteomics standard certification. 3 
Absolute quantitative data can become directly traceable to the generic element-containing certified standard added to 4 
provide consistency of the results and allow for quality-assurance protocols. Of course, such ICP-MS-based approaches 5 
are not intended for comprehensive absolute quantification of the whole set of proteins/peptides in complex samples, but 6 
can be effectively applied to simpler samples such as the SIL peptide/protein standards produced (see Section III.A) that, 7 
once accurately certified, could also be used as internal standards for massive absolute quantifications with LC-MS/MS. 8 
Furthermore, the scope of those ICP-MS-based approaches has been recently extended to moderately complex samples 9 
after demonstration of their potential to simultaneously identify and absolute quantify the proteins of the venoms of 10 
elapid snakes. Absolute quantification provided led to the precise determination of the concentration of the different 11 
toxins (i.e. 25-30) in the venom without the need for any specific standard (Calderón-Celis et al. 2016, 2017). 12 
IV. CONCLUDING REMARKS AND FUTURE PROSPECTS 13 
Immunoassay-based techniques for absolute quantitative proteomics have been stablished as the methods of reference for 14 
decades, mainly due to their sensitivity, selectivity and experimental simplicity with already-stablished protocols. These 15 
approaches are limited not only to specific antibodies availability but also to protein standards of the corresponding 16 
targets required to build the immune calibration curves. Therefore, the development of new protocols for quantitative 17 
study of new target proteins, such as biomarker potential candidates, can become a laborious and long-lasting task. In this 18 
sense, MS has emerged as a powerful technique able to quantitatively characterize up to thousands of proteins in one 19 
experiment. Absolute MS-based approaches have thus been described as the techniques to fill the existing gap in the 20 
process from biomarker discovery to validation, in which there is a lack of quantitative immunoassay-based protocols 21 
(Diamandis 2009). In fact, the potential multiplex for large-scale protein quantification could eventually lead to its 22 
implementation in clinical validation of biomarkers, which has been further reinforced by the development of highly 23 
accurate MS/MS instrumentation (currently considered as class I –low risk- instrumentation by the FDA). However, 24 
there is still insufficient quality control in MS-based approaches to hinder their definitive settlement in legislated clinical 25 
protocols (e.g., diagnosis or disease monitoring), mainly due to the limited availability of properly validated 26 
quantification standards and (certified) reference materials that could be used as controls (Regnier et al. 2010, Boja et al. 27 
2014). 28 
The use of SIL proteotypic peptide standards remains as the approach of reference in absolute quantitative proteomics 29 
with MS. This methodology represents a robust and accurate way to determine peptide/protein absolute quantities in 30 
complex samples and can be used even for very low-abundant analytes when combined with enrichment/purification 31 
methods like SISCAPA. This kind of quantitative approach requires, however, selection of the standard with MS or 32 
MS/MS analysis prior to the quantitative assay. In this sense, several open resources, such as databases and peptides 33 
libraries, have emerged recently that entail a significant aid in such task to facilitate the design of quantification assays 34 
and protocols in proteomics. Moreover, the possibility to use full-length intact proteins as SIL standards prevents some of 35 
the limitations with peptides; e.g., the need to characterize and control the proteolysis step efficiency, and the lack of 36 
control over sample-preparation steps previous to digestion. Yet, the use of either SIL peptides or proteins entails the use 37 
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of stable isotope labeling and thus their use is restricted to availability. Alternatively, the use of isobaric tags as labels in 1 
quantitative proteomics is acknowledged mainly due to its potential multiplexing capabilities for mostly relative but also 2 
absolute quantification of peptides and proteins. 3 
Synthetic production of quantitative standards (labeled or not) can be a simple task because there are a large number of 4 
established protocols for peptide (and even protein) synthesis. However, the limited availability of standards for each 5 
specific peptide/protein target and robust strategies for their proper characterization are obvious limitations. The 6 
outstanding parallel growth of label-free approaches, which are based on computational treatment of the MS data for 7 
quantification instead of the use of specific peptide/protein standards, turns them into potential competitors for extensive 8 
quantitative proteomics in the near future. It should be stressed that, although label-free quantifications are still plagued 9 
today with analytical drawbacks especially in terms of reproducibility and accuracy, it is reasonable to believe that their 10 
successful future is engaged to the specific developments of more-efficient bioinformatics tools. 11 
Finally, the certification of the quantification standards is commonly approached with established but cumbersome and 12 
prone-to-error techniques. In this regard, the use of ICP-MS can provide a simple, fast, and accurate method to certify the 13 
mass purity of such standards. Moreover, the recent synergistic combination of ICP-MS with molecular mass 14 
spectrometry has provided absolute quantification of intact proteins even in relatively complex samples without the need 15 
for any species-unspecific standards. However, its quantitative capacity is constrained by the resolving power of coupled 16 
separation techniques. A major challenge ahead is to develop a robust platform to achieve pre-MS separation of each and 17 
every protein species in the sample. On the other hand, the combination of the advantages of ICP-MS detection with the 18 
selectivity of element-tagged antibodies provides a most-promising tool to tackle the absolute, sensitive, and robust 19 
determination of a few targeted proteins (e.g., panel of biomarkers required for diagnosis and/or prognosis of a given 20 
disease). 21 
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BOXES 1 
BOX 1. Potential areas of interest in biological research benefited from absolute quantitative protein data. 2 
1. Evaluation of protein expression, degradation rates, and variability, and definition of PTMs levels in model 
biological systems 
2. Study of cellular organization and dynamics 
3. Determination of protein stoichiometries and ratio variability within protein complexes 
4. Study of changes of protein levels and activation status in protein networks 
5. Validation of potential new biomarkers and their eventual clinical utility. 
6. Study of potential protein therapeutic agents stability (in biological medium, or upon storage) 
7. Investigation of enzymes kinetics 
8. Development of optimum drug delivery 
9. Pharmacokinetic studies on the behaviors of compounds during drug development 
 3 
  4 
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TABLES 1 
 2 
Table 1. Internal standardization in label-free approaches to control variations in the sample preparation, chromatographic, and MS 3 
performances. 4 
APPROACH DESCRIPTION REF. 
Retention time score 
(iRT) 
Empirical normalized values of a set of specific peptides retention 
times, that are consistent along different LC configurations enabling 
prediction and scaling of peptides chromatographic behavior. 
(Escher et al. 
2012) 
Reversed-phase liquid 
chromatography 
calibrants (RePLiCal) 
Synthetic protein standard that provides peptide calibrant points after 
digestion, to normalize retention times, and evaluate and optimize 
HPLC performance. 
(Holman et al. 
2016) 
Peptide trainer kits 
(PTK) 
Set of synthetic peptides to predict and correct for dynamic retention 
time drifts, re-scheduling the time window that monitor target peptides 
in SRM analysis. 
(Gallien et al. 
2012) 
Halogenated peptides 
as internal standards 
(H-PINS) 
Internal standards that contain halogens, taking advantage of their 
unique isotopic distribution and mass defect, to be used to evaluate 
label-free approaches reproducibility, and to assess labeling reaction 
efficiencies 
(Mirzaei et al. 
2009) 
Pseudo Internal 
Standards (PISs) 
Proteins contained in the sample that do not show variation in 
expression levels among different sample states, used as unlabeled 
internal standards. They are employed to correct for recovery during 
sampling process, as well as for matrix effects. 
(Tabata et al. 
2007) 
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 12 
 13 
 14 
 15 
 16 
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Table 2. Benefits and limitations of using either SIL-peptides or SIL-intact proteins as standards in common mass spectrometry-based 1 
quantification approaches. In any case, the final MS measurement is considered to be carried out at the tryptic peptide level. 2 
 BENEFITS LIMITATIONS 
Peptides 
 Applicability to complex samples (thousands of 
proteins per experiment) 
 More flexibility and accessibility to chemical 
modifications, and easier sequence check out 
 Better chromatographic performance and resolution 
(front-end separation) and quantitative analytical 
recoveries 
 Enhanced MS ionization (higher sensitivity) 
 Easier synthetic preparation, purification, 
characterization, and analysis 
 
 Tryptic digestion efficiency (existence of 
miscleavages) 
 Ambiguity on the origin of redundant peptide 
sequences 
 Extra steps required to determine suitable proteotypic 
peptides if not available in data bases 
 Need for unaltered properties after labeling 
 Reactive or labile amino acids are to be avoided 
 Later addition does not correct for initial protein 
losses 
 If peptides are low abundant or badly ionized, MS 
information might lead to inaccurate quantification 
Proteins 
 The standard can be added to the crude sample at 
first stages of the process: full characterization, and 
correction for losses of protein or tryptic digestion 
incomplete efficiency 
 Complete characterization of the analytical process 
 Possibility to measure at the protein or peptide level 
(after digestion) 
 If protein is digested after spiked, there would be 
more potentially MS-detectable SIL peptides than if 
a single SIL peptide is added, thus quantification is 
statistically more reliable 
 Likely non-quantitative analytical recoveries 
(fractionation and/or separation steps) 
 Limited dynamic range (high-abundant proteins might 
hinder analysis of low-abundant ones) 
 Structure has to be identical to the endogenous 
protein, and properties need to remain unaltered after 
labeling 
 Complicated synthesis labeling, purification, and 
quantitative certification 
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FIGURES 1 
 2 
 3 
Figure 1. Timeline of standard addition in the main absolute protein quantification strategies with molecular MS during a model 4 
quantitative proteomics analysis workflow, adapted from (Malmström et al. 2009, Wang et al. 2016). 5 
 6 
 7 
 8 
 9 
 10 
Figure 2. Isobaric tags for peptide/protein quantification. A) iTRAQ reagent, adapted from (Ross et al. 2004). The reactive group is 11 
usually based on N-methylpiperazine, and can have up to four 
13
C and two 
15
N, the mass balance group is a carbonyl group with can 12 
have up to two 
13
C and two 
18
O, in such a way that the overall mass of the isobaric tags are the same. The reactive group is usually 13 
based on a NHS ester group that reacts with the peptides amines forming an amide bounding. B) Tandem mass tag reagent, adapted 14 
from (Dayon et al. 2008). Similarly, to iTRAQ reagents, it comprises a reporter group (detected by MS) and a mass normalization group, 15 
of identical overall mass in the different reagents, and a reactive group. The reactive group is commonly an amine reactive group, 16 
although TMTs bearing carbonyl reactivity have been reported though hydrazide- and aminooxy-functionalized reactive groups (Hahne et 17 
al. 2012). 18 
 19 
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 1 
Figure 3. ICP-detectable heteroatom source and standardization timeline in the main elemental MS-based absolute quantitative 2 
proteomics strategies. 3 
 4 
 5 
 6 
Figure 4. Scheme of an “absolute” quantitative proteomics workflow based on combining elemental and molecular MS detection after 7 
identical separation (HPLC) conditions, adapted from (Calderón-Celis et al. 2016). ICP-MS: the sample containing the sought analyte is 8 
spiked with a species-unspecific standard containing the detected heteroatom. After LC separation, heteroatom absolute content of the 9 
standard and the analyte(s) is accomplished by on-line isotope dilution analysis (mass flow equation, MFs, Figure 7.C) by relating the 10 
peak areas of the standard (of known concentration added to the sample to correct for injection errors and simplify IDA computations) and 11 
the analytes. ESI-MS: the detection of the analyte species provides their identification and/or sequence characterization, either with MS 12 
and MS/MS analysis (i.e., top-down workflow), or with accurate MS analysis together with database information. This provides the 13 
39 
stoichiometry heteroatom:protein molecule, hence the absolute amount of the corresponding protein can be finally obtained from the 1 
element content determined. 2 
 3 
 4 
 5 
Figure 5. Chemical structures of labeling reagents in ICP-MS approaches. A) Scheme of bifunctional reagents, which consist on a 6 
chelating group that bonds the ICP-MS detected heteroelement (mostly metals), a bridge or main body of the reagent, and a recognition 7 
group that reacts to the sought analyte. B) Schematic representation of MeCAT reagent, adapted from (Ahrends et al. 2007). It contains a 8 
DOTA macrocycle for metal chelating, a spacer that connects the macrocycle and the maleimido reactive group that specifically reacts to 9 
thiol groups. The spacer might contain a biotin group for purification. C) Mercury tags: p-chloromercurybenzoate, p-10 
hydroxymercurybenzoate, methyl-mercury, ethyl-mercury, adapted from (Tholey and Schaumlöffel 2010). D) Iodination reaction using bis-11 
pyridinium iodinium tetrafluoroborate as reactive agent, adapted from (Pereira Navaza et al. 2009).  12 
 13 
40 
 1 
Figure 6. Strategies of peptide/protein standards synthesis: A) Chemical synthesis based on solid phase supports (SPPS), adapted from 2 
(Amblard et al. 2006). The amino acids are added in excess in order to assure maximal yield and in the desired order in each step of the 3 
synthesis. They are N-terminal protected, usually with tert-butyloxycarbonyl (t-Boc) or 9H-fluoren-9-ylmethoxycarbonyl (Fmoc) groups, in 4 
order to prevent self-coupling of the amino acids to compete with the peptide chain synthesis. The assembling process is usually 5 
controlled by monitoring with spectrophotometry the amount of Fmoc removed at each deprotection/coupling cycle (Coin et al. 2007), 6 
whereas the synthesis process can be controlled by measuring quantitatively the peptide chain or the unreacted free amino acids by the 7 
ninhydrin reaction (Sarin et al. 1981).Deprotection step is usually carried out with TFA when BOC is the protecting group and with 8 
Piperidine/DMF when it is FMOC. Cleavage step is usually carried out with high concentration of TFA, together with phenol and TIPS. B) 9 
Metabolic synthesis through concatemerization. Firstly, the proteotypic quantification peptides that correspond to the target proteins are 10 
selected and synthesized together as a single protein through the corresponding synthetic designed gene. Gene expression can be 11 
performed in a medium that contains isotopically enriched lysine and arginine to produce isotope-labeled standards. C) Chemical ligation 12 
through chemoselective reaction for the union of peptides, adapted from (Dawson and Kent 2000). D) Metabolic synthesis with the PURE 13 
system, adapted from (Xian et al. 2016). From the synthetic DNA precursor (previously amplified by PCR from synthetic oligonucleotides), 14 
the sought peptide or protein is synthesized with the PURE kit, which contains the required isolated enzymes, amino acids (which can be 15 
isotopically labeled), ribosomes, and RNAs. All recombinant protein components of the system are His-tagged, allowing purification of the 16 
synthesized untagged protein by removing the rest of the system’s components. E) FLEXIQuant synthesis strategy, adapted from (Singh 17 
et al. 2012). The gene of interest is cloned into a wheat germ expression vector, and transcribed and translated in a wheat germ extract 18 
(WGE) in the presence of selected heavy isotope-labeled amino acids ([
13
C, 
15
N] arginine and lysine), which provides the in vitro 19 
expression of the full-length labeled protein standards. 20 
 21 
 22 
41 
 1 
Figure 7. A) Concept of isotope dilution, adapted from (Rodríguez-González et al. 2005). A sample with natural isotopic abundance of the 2 
target compound or element is mixed with a spike isotopically enriched in a non-abundant isotope in a known isotopic composition. The 3 
final mixture is analyzed, the concentration of the sample can be calculated from the abundances of the measured isotopes. B) Isotope 4 
dilution equation in species-specific IDA approaches that express the moles of target element in a sample (s), as a function of the moles 5 
of element in the isotopically enriched spike (sp), the experimental ratios of two isotopes (1 and 2) of the element in a mixture of sample 6 
and spike (Rm), and the element isotopic abundances in the sample, A
1
S and A
2
S (i.e. IUPAC isotopic abundances), and in the spike, A
1
Sp 7 
and A
2
Sp (therefore requiring previous characterization). C) Mass flow equation for species-unspecific IDA approaches. The sample’s 8 
mass flow (MFs) is expressed as function of the element concentration in the spike (Csp), the density and flow of the spike (dsp and fsp), 9 
the atomic weights of the element in the sample and the spike (Aws and Awsp), Rm, A
1
S, A
2
Sp,and the isotope ratios in the sample and 10 
spike (Rs and Rsp), adapted from (Rodríguez-González et al. 2005). 11 
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